Hereditary hemorrhagic telangiectasia diagnosis and management from the

  • Slides: 8
Download presentation
Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist’s perspective by Athena Kritharis, Hanny

Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist’s perspective by Athena Kritharis, Hanny Al-Samkari, and David J Kuter haematol Volume 103(9): 1433 -1443 August 31, 2018 © 2018 by Ferrata Storti Foundation

Classification and genetics of the most common hereditary human telangiectasia (HHT) subtypes. Athena Kritharis

Classification and genetics of the most common hereditary human telangiectasia (HHT) subtypes. Athena Kritharis et al. Haematologica 2018; 103: 1433 -1443 © 2018 by Ferrata Storti Foundation

Molecular pathophysiology of hereditary hemorrhagic telangiectasia (HHT). Athena Kritharis et al. Haematologica 2018; 103:

Molecular pathophysiology of hereditary hemorrhagic telangiectasia (HHT). Athena Kritharis et al. Haematologica 2018; 103: 1433 -1443 © 2018 by Ferrata Storti Foundation

Clinical manifestations of telangiectasias. Athena Kritharis et al. Haematologica 2018; 103: 1433 -1443 ©

Clinical manifestations of telangiectasias. Athena Kritharis et al. Haematologica 2018; 103: 1433 -1443 © 2018 by Ferrata Storti Foundation

Screening and management of hereditary human telangiectasia patients. Athena Kritharis et al. Haematologica 2018;

Screening and management of hereditary human telangiectasia patients. Athena Kritharis et al. Haematologica 2018; 103: 1433 -1443 © 2018 by Ferrata Storti Foundation

Treatment algorithm for iron deficiency anemia in hereditary hemorrhagic telangiectasia (HHT). Athena Kritharis et

Treatment algorithm for iron deficiency anemia in hereditary hemorrhagic telangiectasia (HHT). Athena Kritharis et al. Haematologica 2018; 103: 1433 -1443 © 2018 by Ferrata Storti Foundation

Bevacizumab treatment course in a 71 -year-old woman with hereditary hemorrhagic telangiectasia (HHT) and

Bevacizumab treatment course in a 71 -year-old woman with hereditary hemorrhagic telangiectasia (HHT) and chronic gastrointestinal bleeding and epistaxis. Athena Kritharis et al. Haematologica 2018; 103: 1433 -1443 © 2018 by Ferrata Storti Foundation

Published data using bevacizumab to treat chronic bleeding in hereditary human telangiectasia are patients.

Published data using bevacizumab to treat chronic bleeding in hereditary human telangiectasia are patients. Athena Kritharis et al. Haematologica 2018; 103: 1433 -1443 © 2018 by Ferrata Storti Foundation